Enzymatica AB — Investor Relations & Filings

Enzymatica AB is a life science company that develops and sells medical devices for infection-related diseases. The company's products are based on a proprietary barrier technology that utilizes a marine enzyme to form a protective layer in the mouth and throat. This barrier deactivates viruses and supports the body's natural defenses against microorganisms. Its primary product, ColdZyme®, is an oral spray designed to help prevent common colds and can shorten the duration of symptoms by targeting the underlying cause of the infection.